Search research articles
Contact Us
Filters
Showing results (261-270 of 1,374) with videos related to
Page
of 138
Sort By:
Drug Development Research
|
February 15, 2024
Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents
Aya M Soliman, Ahmed M K El-Sagheir, Momen M Thabet, et al.
Drug Development Research
|
February 13, 2024
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment
Chiara Vagaggini, Debora Petroni, Ilaria D'Agostino, et al.
Drug Development Research
|
March 22, 2024
Pyridazine and pyridazinone derivatives: Synthesis and in vitro investigation of their anti-inflammatory potential in LPS-induced RAW264.7 macrophages
Eman O Osman, Nadia A Khalil, Alaa Magdy, et al.
Drug Development Research
|
March 14, 2024
Xanthones with multiple roles against diabetes: their synthesis, structure-activity relationship, and mechanism studies
Youhong Ke, Qinfang Xu, Jianling Hu, et al.
Drug Development Research
|
March 6, 2024
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
Hefen Chen, Zhujun Gong, Hong Zhou, et al.
Drug Development Research
|
March 7, 2024
Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathway
Zhou Liang, Hongsheng He, Bing Zhang, et al.
Drug Development Research
|
July 3, 2024
Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin-2-one derivatives
Gulseren Turhal, Busra Demirkan, Izel Nermin Baslilar, et al.
Drug Development Research
|
September 10, 2024
A thiourea-bridged <sup>99m</sup>Tc(CO)<sub>3</sub>-dipicolylamine-2-nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea-bridge to improve pharmacokinetics
Sweety Mittal, Chandan Kumar, Laxmi Jha, et al.
Drug Development Research
|
September 9, 2024
A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies
Chen Zhao, Yuan Zeng, Nannan Kang, et al.
Drug Development Research
|
September 10, 2024
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dan-Dan Shen, Yue-Lin Zhang, Xiang Li, et al.
Page
of 138
Search research articles
Search
Showing results (261-270 of 1,374) with videos related to
Sort By:
Page
of 138
Drug Development Research
|
February 15, 2024
Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents
Aya M Soliman, Ahmed M K El-Sagheir, Momen M Thabet, et al.
Drug Development Research
|
February 13, 2024
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment
Chiara Vagaggini, Debora Petroni, Ilaria D'Agostino, et al.
Drug Development Research
|
March 22, 2024
Pyridazine and pyridazinone derivatives: Synthesis and in vitro investigation of their anti-inflammatory potential in LPS-induced RAW264.7 macrophages
Eman O Osman, Nadia A Khalil, Alaa Magdy, et al.
Drug Development Research
|
March 14, 2024
Xanthones with multiple roles against diabetes: their synthesis, structure-activity relationship, and mechanism studies
Youhong Ke, Qinfang Xu, Jianling Hu, et al.
Drug Development Research
|
March 6, 2024
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
Hefen Chen, Zhujun Gong, Hong Zhou, et al.
Drug Development Research
|
March 7, 2024
Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathway
Zhou Liang, Hongsheng He, Bing Zhang, et al.
Drug Development Research
|
July 3, 2024
Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin-2-one derivatives
Gulseren Turhal, Busra Demirkan, Izel Nermin Baslilar, et al.
Drug Development Research
|
September 10, 2024
A thiourea-bridged <sup>99m</sup>Tc(CO)<sub>3</sub>-dipicolylamine-2-nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea-bridge to improve pharmacokinetics
Sweety Mittal, Chandan Kumar, Laxmi Jha, et al.
Drug Development Research
|
September 9, 2024
A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignancies
Chen Zhao, Yuan Zeng, Nannan Kang, et al.
Drug Development Research
|
September 10, 2024
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dan-Dan Shen, Yue-Lin Zhang, Xiang Li, et al.
Page
of 138